3.3 Transcutaneous Pacing (TCP) Operation & Management

3.3 Transcutaneous Pacing (TCP) Operation & Management

Indications for Transcutaneous Pacing

Transcutaneous pacing (TCP) is a vital, life-saving intervention in the management of symptomatic bradycardia. It is indicated as a primary intervention for patients who are hemodynamically unstable and unresponsive to Atropine therapy. Furthermore, TCP is the preferred initial treatment—often bypassing Atropine altogether—for patients presenting with high-degree AV blocks, specifically Mobitz Type II second-degree AV block and third-degree (complete) AV block with a wide QRS complex. In these infranodal blocks, Atropine is likely to be ineffective and potentially harmful, making TCP the most appropriate and immediate course of action. TCP may also be initiated immediately in patients with profound instability (e.g., severe cardiogenic shock or impending cardiac arrest) where waiting for Atropine to take effect would be detrimental.

Step-by-Step Setup and Operation

Proper setup and operation of the transcutaneous pacemaker require systematic execution to ensure efficacy and patient safety. The procedure involves applying pacing pads, setting the rate, and titrating the electrical current to achieve capture.

1. Pad Placement

The first step is the correct application of the pacing/defibrillation pads. The preferred position for TCP is the anterior-posterior (AP) placement. The anterior pad is placed on the left chest, halfway between the xiphoid process and the left nipple, while the posterior pad is placed on the left upper back, beneath the scapula. The AP position is optimal because it sandwiches the heart directly between the two electrodes, lowering the pacing threshold required to achieve electrical capture and minimizing skeletal muscle contraction. If AP placement is not feasible, the standard anterolateral (sternum/apex) placement used for defibrillation may be utilized, though it may require higher energy outputs.

2. Rate Setting

Once the pads are applied and connected to the monitor/defibrillator, the pacing function is activated. The initial pacing rate should be set between 60 and 80 beats per minute (bpm). This rate is generally sufficient to restore adequate cardiac output and reverse the signs of hemodynamic instability without causing excessive myocardial oxygen demand. The rate can be adjusted based on the patient's clinical response, but a target of 60 to 80 bpm is the standard starting point.

3. Current (mA) Titration and Electrical Capture

The next critical step is titrating the electrical current (measured in milliamperes, or mA) to achieve electrical capture. The provider begins with the current set at 0 mA and gradually increases the output. Electrical capture is observed on the cardiac monitor when every pacing spike is immediately followed by a wide QRS complex and a broad T wave. This distinctive morphology indicates that the electrical impulse has successfully depolarized the ventricles. The provider should slowly increase the mA until consistent electrical capture is achieved. Once capture is confirmed, it is common practice to set the final mA output slightly above the capture threshold (typically 2 to 10 mA higher) to ensure a safety margin.

Verification of Mechanical Capture

Electrical capture on the monitor does absolutely not guarantee that the heart is physically contracting and generating a pulse. This phenomenon, known as pulseless electrical activity (PEA), can occur if the myocardium is too damaged to respond mechanically to the electrical stimulus. Therefore, verifying mechanical capture is a mandatory step. Mechanical capture is confirmed by palpating a central pulse—specifically the femoral or carotid pulse—and ensuring that the pulse rate matches the set pacing rate. It is critical to note that the provider must not rely on palpating the pulse on the left side of the neck or chest, as the violent skeletal muscle contractions caused by the pacing current can be easily mistaken for a true pulse. The femoral pulse is often the most reliable location for this assessment.

Analgesia and Sedation Management

Transcutaneous pacing is an inherently painful procedure. The electrical current required to penetrate the chest wall and capture the myocardium causes intense, involuntary contractions of the skeletal muscles in the chest and back. For a conscious patient, this can be agonizing and highly distressing. Therefore, providing adequate analgesia and sedation is a crucial component of TCP management.

Whenever possible, and if the patient's blood pressure allows, the provider should administer parenteral narcotics (such as fentanyl or morphine) for pain relief and a benzodiazepine (such as midazolam) for sedation and anxiolysis. However, the initiation of pacing for an unstable patient must never be delayed while waiting to administer sedation. If the patient is critically unstable or unconscious, pacing must begin immediately. Once the patient's hemodynamic status improves and they become more alert, sedation and analgesia should be provided promptly to maintain comfort and compliance with the therapy. Continuous reassessment of the patient's pain level and hemodynamic status is required throughout the duration of transcutaneous pacing.